Use of Continuous-Infusion Ceftolozane/Tazobactam in a Multidrug-Resistant Pseudomonas aeruginosa Urinary Tract Infection in the Outpatient Setting

被引:16
作者
Jones, Bruce M. [1 ]
Smith, Bradley [1 ]
Bland, Christopher M. [1 ,2 ]
机构
[1] St Josephs Candler Hlth Syst Inc, Savannah, GA USA
[2] Univ Georgia, Coll Pharm, Athens, GA 30602 USA
关键词
D O I
10.1177/1060028017701938
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:715 / 716
页数:2
相关论文
共 50 条
  • [31] Intravitreal piperacillin/tazobactam in the management of multidrug-resistant Pseudomonas aeruginosa endophthalmitis
    Pathengay, Avinash
    Mathai, Annie
    Shah, Gaurav Y.
    Ambatipudi, Srinivas
    [J]. JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2010, 36 (12) : 2210 - 2211
  • [32] Polimixin B use in treatment of multidrug-resistant Pseudomonas aeruginosa infection
    LS Gouveia
    ML Ribeiro-Neto
    LA Ferreira
    VB Viana
    FM Paes
    AR Farias
    SA Souza-Filho
    JM Teles
    L Espinheira
    OM Messeder
    [J]. Critical Care, 7 (Suppl 3):
  • [33] Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients
    Coppola, Paolo E.
    Gaibani, Paolo
    Sartor, Chiara
    Ambretti, Simone
    Lewis, Russell E.
    Sassi, Claudia
    Pignatti, Marco
    Paolini, Stefania
    Curti, Antonio
    Castagnetti, Fausto
    Ursi, Margherita
    Cavo, Michele
    Stanzani, Marta
    [J]. MICROORGANISMS, 2020, 8 (12) : 1 - 11
  • [34] Ceftolozane-tazobactam vs. colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa : a multicentre cohort study
    Almangour, Thamer A.
    Aljabri, Ahmad
    Al Musawa, Mohammed
    Almohaizeie, Abdullah
    Almuhisen, Sara
    Damfu, Nader
    Alfozan, Awaly
    Alraddadi, Basem M.
    Alattas, Majda
    Qutub, Mohammed
    Alhameed, Abrar F.
    Khuwaja, Malik
    Alghamdi, Ahlam
    Binkhamis, Khalifa M.
    Alfahad, Wafa
    AIShahrani, Fatimah S.
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 28 : 288 - 294
  • [35] Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model
    María M. Montero
    Sandra Domene-Ochoa
    Carla López-Causapé
    Sonia Luque
    Luisa Sorlí
    Núria Campillo
    Eduardo Padilla
    Núria Prim
    Lorena Ferrer-Alapont
    Ariadna Angulo-Brunet
    Santiago Grau
    Antonio Oliver
    Juan P. Horcajada
    [J]. Scientific Reports, 11
  • [36] Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients
    Morgan Hakki
    James S. Lewis
    [J]. Infection, 2018, 46 : 431 - 434
  • [37] Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model
    Montero, Maria M.
    Domene-Ochoa, Sandra
    Lopez-Causape, Carla
    Luque, Sonia
    Sorli, Luisa
    Campillo, Nuria
    Padilla, Eduardo
    Prim, Nuria
    Ferrer-Alapont, Lorena
    Angulo-Brunet, Ariadna
    Grau, Santiago
    Oliver, Antonio
    Horcajada, Juan P.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] Microbiological and molecular studies on a multidrug-resistant Pseudomonas aeruginosa from a liver transplant patient with urinary tract infection in Egypt
    Shaaban, Mohamed T.
    Abdel-Raouf, Mohamed
    Zayed, Muhammad
    Emara, Mahmoud A.
    [J]. BMC MICROBIOLOGY, 2024, 24 (01):
  • [39] In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020
    Karlowsky, James A.
    Lob, Sibylle H.
    Siddiqui, Fakhar
    Akrich, Brune
    DeRyke, C. Andrew
    Young, Katherine
    Motyl, Mary R.
    Hawser, Stephen P.
    Sahm, Daniel F.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 61 (05)
  • [40] Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study
    Almangour, Thamer A.
    Ghonem, Leen
    Alassiri, Dareen
    Aljurbua, Alanoud
    Al Musawa, Mohammed
    Alharbi, Aminah
    Almohaizeie, Abdullah
    Almuhisen, Sara
    Alghaith, Jeelan
    Damfu, Nader
    Aljefri, Doaa
    Alfahad, Wafa
    Khormi, Yaqoub
    Alanazi, Menyfah Q.
    Alsowaida, Yazed Saleh
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (08)